Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
Shintaro NaritaKyoko NomuraShingo HatakeyamaMasahiro TakahashiToshihiko SakuraiSadafumi KawamuraSenji HoshiMasanori IshidaToshiaki KawaguchiShigeto IshidoyaJiro ShimodaHiromi SatoKoji MitsuzukaTatsuo TochigiNorihiko TsuchiyaChikara OhyamaYoichi AraiKengo NagashimaTomonori HabuchiPublished in: Cancer medicine (2019)
The conditional 5-year net CSS and OS in patients with mHNPC gradually increased; thus, the risk of mortality decreased with increasing survival. The patient's risk profile changed over time. EOD remained an independent prognostic factor for CSS and OS after 5-year follow-up. Conditional net survival can play a role in clinical decision-making, providing intriguing information for cancer survivors.